Clinical Trial Update: Dexamethasone Compared With Dexmedetomidine as an Adjuvant to Ropivacaine for Supraclavicular Brachial Plexus Block [Phase 3]

View source ↗

Summary

Phase 3 trial comparing dexamethasone versus dexmedetomidine as adjuvants to ropivacaine in supraclavicular brachial plexus block has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brachial Plexus Block

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Dexmedetomidine (Dexmedetomidine)
• Ropivacaine (Ropivacaine)

Snippet

Sponsor: B.P. Koirala Institute of Health Sciences | Conditions: Brachial Plexus Block | Phase 3 | Status: COMPLETED